After years of development, Cube Group has efficiently integrated the company's internal technology, management resources and external market resources, and created a proprietary technology platform with "osmotic pump controlled release technology" and "separation technology" as the core. The company has successively undertaken more than 10 scientific research projects, such as the Innovation Fund of the Ministry of Science and Technology, Torch Plan, and major special projects of Anhui Science and Technology Department, and obtained 5 authorized invention patents. Felodipine sustained-release tablets, paeonol ointment, Kunning granules, Liang Jun oral liquid and other products enjoy high reputation in the market. At the same time, a terminal promotion network covering 29 provinces and cities across the country has been established.
Hefei Cubic Pharmaceutical Group adheres to the business tenet of "Cubic Saving the World, Sincerely Dedicating", follows the marketing concept of "Marketing as Service", takes human health as its own responsibility, pursues institutionalized management with efficiency as its core, and always makes unremitting efforts to enhance the value and quality of human life.